A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer
Clinical trial NCT00808418 · COMPLETED
Trial details
- NCT number
- NCT00808418
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-05-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.